Epidemiological trends of lung cancer attributed to residential radon exposure at global, regional, and national level: a trend analysis study from 1990 to 2021
Authors:
Open Access
- 2 May 2025
- journal article
- public health
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1593415
Abstract
Background: Lung cancer (LC) remains a leading cause of cancer-related mortality globally, with radon identified as the second major risk factor. This study aimed to analyze the global, regional, and national burden of LC attributed to residential radon exposure from 1990 to 2021.Methods: The Global Burden of Disease (GBD) 2021 database were employed to estimate the disease trends of LC attributed to residential radon exposure across sex, age groups, and socioeconomic development levels via the socio-demographic index (SDI). Trends of the age-standardized rates (ASRs) were evaluated using estimated annual percentage change (EAPC). The relationship of the socio-demographic index (SDI) with ASRs was assessed via Spearman correlation and LOESS regression.Results: In 2021, residential radon caused 82,160 global LC deaths (an increase of 66.87% since 1990), while the ASRs declined globally (ASMR EAPC: −0.26, 95%C: −0.51 to −0.01; ASDR EAPC: −0.65, 95%CI: −0.85 to −0.44). The disease burden of residential radon-induced LC was higher in middle and high latitude nations. With the increase of SDI, ASRs showed a downward trend in most regions, while an upward trend at national level. Across age and sex, the older adult males exhibited higher burden.Conclusion: While global ASRs declined, rising absolute burdens underscore radon’s persistent threat, particularly in rapidly urbanizing and high-latitude regions. Targeted radon mitigation, enhanced early detection, and gender-specific interventions are critical.Keywords
This publication has 29 references indexed in Scilit:
- Global, regional, and national burden of tracheal, bronchus, and lung cancer and its risk factors from 1990 to 2021: findings from the global burden of disease study 2021eClinicalMedicine, 2024
- Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet, 2024
- Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet, 2024
- Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet, 2024
- Updated risk models for lung cancer due to radon exposure in the German Wismut cohort of uranium miners, 1946–2018Radiation and Environmental Biophysics, 2023
- An overview on the relationship between residential radon and lung cancer: what we know and future researchClinical and Translational Oncology, 2023
- Nowcasting and forecasting the care needs of the older population in China: analysis of data from the China Health and Retirement Longitudinal Study (CHARLS)The Lancet Public Health, 2022
- Opinion on reconsideration of lung cancer risk from domestic radon exposureRadiation Medicine and Protection, 2020
- Radon interventions around the globe: A systematic reviewHeliyon, 2019
- Variance of indoor radon concentration: Major influencing factorsScience of The Total Environment, 2016